Essential hypertension Trials in Seoul, South Korea
Conditions / Essential hypertension / Seoul, South Korea
Clinical trials for Essential hypertension investigate a range of treatment strategies and patient populations.
53 total trials for this combination
Showing top 10 of 53 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06636877 | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1019 and Co-administration of BR1019-3 and BR1019-2 in Healthy Volunteers | COMPLETED | PHASE1 |
| NCT01785472 | Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension | COMPLETED | PHASE3 |
| NCT01541943 | Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia | COMPLETED | PHASE3 |
| NCT06226727 | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1019 and Co-administration of BR1019-1 and BR1019-2 | COMPLETED | PHASE1 |
| NCT06682000 | Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension | COMPLETED | PHASE3 |
| NCT06212648 | Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension | COMPLETED | PHASE2 |
| NCT01663233 | Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine | COMPLETED | PHASE3 |
| NCT06084065 | Feasibility and Effectiveness of a Ring-type Blood Pressure Measurement Device | UNKNOWN | NA |
| NCT01615198 | Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension | COMPLETED | PHASE3 |
| NCT06220773 | A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy | RECRUITING | PHASE3 |